Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02335710 · ClinicalTrials.gov registry record

Optimized Loading Response by JOURNEY II BCS Knee Increases Daily Physical Activity and Functions

A clinical trial, sponsored by The University of Tennessee, Knoxville.

Completed
Registry status
50
Enrollment target

NCT02335710 is a clinical trial that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02335710 has completed, sponsored by The University of Tennessee, Knoxville.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

Smith \& Nephew's first edition of the Journey posterior stabilizing total knee arthroplasty was analyzed by the Center for Musculoskeletal Research in a past research study, and it was determined that subjects experienced more normal-like kinematic patterns. They also achieved excessive axial rotation and a decrease in weight-bearing knee flexion. Since Smith \& Nephew has made modifications to the Journey bi-cruciate stabilizing (BCS) total knee arthroplasty (TKA) design, researchers will again evaluate the kinematics of subjects implanted with the revised design to determine if subjects experience normal-like kinematic patterns and if greater weight-bearing knee flexion is achieved. The objective for this study is to analyze the in vivo kinematics for subjects implanted with a 2nd generation Journey BCS TKA and compare those patterns to subjects having a normal knee and those having the 1st generation Journey posterior stabilizing (PS) TKA that were analyzed in the previous study.

Interventions

  • DEVICE Journey II BCS TKA

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-07
Est. Completion 2016-07

What the Registry Record Tells You About NCT02335710

The ClinicalTrials.gov registry entry for NCT02335710 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Tennessee, Knoxville, which has 81 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Journey II BCS TKA is the first listed.

NCT02335710 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02335710 about?

NCT02335710 is a clinical study titled "Optimized Loading Response by JOURNEY II BCS Knee Increases Daily Physical Activity and Functions". Smith \& Nephew's first edition of the Journey posterior stabilizing total knee arthroplasty was analyzed by the Center for Musculoskeletal Research in a past research study, and it was determined that subjects experienced more normal-like kinematic patterns. They also achieved excessive axial rotat...

What is the current status of trial NCT02335710?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-07. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02335710?

The interventions under investigation include: Journey II BCS TKA (DEVICE).

Who is sponsoring clinical trial NCT02335710?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.